Today we had the pleasure of being joined by Associate Professor Patrick Phillips from the University of California, who is the Co-Director of the UC Tuberculosis Research Advancement Center, Clinical & Population Health Science Core. Patrick has a wealth of statistical experience and specialises in the design, implementation, and optimisation of clinical trials for new treatments for drug-sensitive and drug-resistant tuberculosis.

Join us as we explore the rapidly evolving field of TB clinical trials and drug development. Discover the latest advancements in surrogate selection, novel Bayesian phase II designs, and the future of adaptive trial designs. We also delve into the critical clinician-statistician interface, highlighting the exciting opportunities for TB clinicians today.

• 10.1186/s12879-022-07846-w